Your browser is no longer supported. Please, upgrade your browser.
Globus Medical, Inc.
Index- P/E42.32 EPS (ttm)1.81 Insider Own1.11% Shs Outstand100.45M Perf Week0.47%
Market Cap7.93B Forward P/E34.35 EPS next Y2.23 Insider Trans-27.08% Shs Float77.07M Perf Month-6.37%
Income184.00M PEG3.48 EPS next Q0.45 Inst Own70.30% Short Float1.52% Perf Quarter-2.18%
Sales927.90M P/S8.55 EPS this Y-33.40% Inst Trans0.06% Short Ratio2.74 Perf Half Y10.45%
Book/sh16.32 P/B4.68 EPS next Y10.75% ROA10.80% Target Price86.21 Perf Year38.51%
Cash/sh4.44 P/C17.23 EPS next 5Y12.17% ROE12.00% 52W Range49.36 - 84.23 Perf YTD17.19%
Dividend- P/FCF39.11 EPS past 5Y-2.90% ROI5.80% 52W High-9.26% Beta1.08
Dividend %- Quick Ratio5.10 Sales past 5Y7.70% Gross Margin74.50% 52W Low54.84% ATR1.85
Employees2200 Current Ratio6.90 Sales Q/Q68.60% Oper. Margin22.50% RSI (14)43.48 Volatility1.63% 2.39%
OptionableYes Debt/Eq0.00 EPS Q/Q287.90% Profit Margin19.80% Rel Volume0.76 Prev Close77.15
ShortableYes LT Debt/Eq0.00 EarningsAug 04 AMC Payout0.00% Avg Volume426.87K Price76.43
Recom2.30 SMA20-2.37% SMA50-3.62% SMA2006.29% Volume324,060 Change-0.93%
Feb-18-21Resumed Needham Buy $65 → $75
Dec-08-20Initiated Citigroup Buy $72
Oct-20-20Initiated Stifel Hold $56
Aug-06-20Upgrade Northland Capital Market Perform → Outperform $65
Aug-06-20Reiterated Needham Buy $60 → $65
Jul-21-20Initiated Northland Capital Market Perform $50
Jul-06-20Downgrade Piper Sandler Overweight → Neutral $60 → $50
May-08-20Reiterated Needham Buy $63 → $60
Mar-18-20Upgrade BTIG Research Neutral → Buy $46
Jan-08-20Initiated SunTrust Buy $67
Dec-12-19Upgrade Wells Fargo Market Perform → Outperform $63
Aug-02-19Reiterated Needham Buy $52 → $56
May-24-19Downgrade Wells Fargo Outperform → Market Perform $41
May-03-19Reiterated Needham Buy $57 → $52
Feb-28-19Upgrade UBS Neutral → Buy $55
Jan-02-19Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-02-18Reiterated Needham Buy $58 → $65
Jun-27-18Downgrade BofA/Merrill Neutral → Underperform
Jun-01-18Initiated Cantor Fitzgerald Overweight
May-03-18Reiterated Needham Buy $57 → $58
Oct-14-21 05:01PM  
Oct-13-21 04:30PM  
Oct-12-21 11:31AM  
Sep-28-21 10:17AM  
Sep-27-21 04:30PM  
Sep-22-21 09:48AM  
Sep-06-21 09:20AM  
Sep-03-21 11:31AM  
Aug-17-21 10:11AM  
Aug-16-21 04:30PM  
Aug-05-21 08:37AM  
Aug-04-21 06:15PM  
Aug-03-21 12:10PM  
Aug-02-21 09:27AM  
Jul-29-21 11:54AM  
Jul-28-21 03:04PM  
Jul-26-21 12:45PM  
Jul-23-21 09:29AM  
Jul-16-21 08:42AM  
Jul-15-21 04:30PM  
Jul-13-21 10:57AM  
Jun-30-21 06:42AM  
Jun-29-21 06:48AM  
Jun-28-21 04:28AM  
Jun-21-21 04:29PM  
Jun-03-21 11:31AM  
May-28-21 03:35AM  
May-06-21 10:07AM  
May-05-21 08:25AM  
May-04-21 06:05PM  
Apr-21-21 04:30PM  
Apr-16-21 08:58AM  
Apr-15-21 04:30PM  
Apr-12-21 03:49PM  
Apr-08-21 09:16AM  
Mar-30-21 04:09AM  
Mar-29-21 02:01PM  
Mar-19-21 11:30AM  
Feb-28-21 03:40AM  
Feb-18-21 12:30AM  
Feb-17-21 04:47PM  
Feb-10-21 12:31PM  
Jan-29-21 01:37AM  
Jan-28-21 04:30PM  
Jan-19-21 10:30AM  
Dec-21-20 04:33PM  
Dec-18-20 08:57AM  
Dec-09-20 04:30PM  
Dec-08-20 09:36AM  
Dec-07-20 01:17PM  
Dec-01-20 09:58AM  
Nov-27-20 11:31AM  
Nov-12-20 04:30PM  
Oct-29-20 11:08AM  
Oct-28-20 06:15PM  
Oct-21-20 12:32PM  
Oct-20-20 09:56AM  
Oct-16-20 04:30PM  
Oct-07-20 11:20AM  
Oct-06-20 10:27AM  
Oct-05-20 04:30PM  
Sep-17-20 10:34AM  
Sep-14-20 11:35PM  
Sep-04-20 12:08PM  
Aug-20-20 10:46AM  
Aug-10-20 08:20AM  
Aug-05-20 06:35PM  
Aug-04-20 11:25AM  
Jul-29-20 12:33PM  
Jul-21-20 04:15PM  
Jun-23-20 07:40PM  
Jun-09-20 10:05AM  
May-27-20 08:09AM  
May-20-20 03:56PM  
May-09-20 09:34AM  
May-08-20 09:30PM  
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products, comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue based products; and COALITION, COALITION MIS, COALITION AGX, MONUMENT, MAGNIFY-S, HEDRON IATM, HEDRON ICTM, INDEPENDENCE, INDEPENDENCE MIS, FORTIFY and XPAND families, SABLETM, RISE, RISE INTRALIF, RISE-L, ELSA, ELSA ATP, RASS, ALTERA, ARIEL, LATIS, CALIBER and CALIBER-L products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pfeil Keith WSVP, Chief Financial OfficerAug 19Option Exercise53.2783344,374833Aug 23 04:41 PM
Pfeil Keith WSVP, Chief Financial OfficerAug 19Sale76.1383363,4160Aug 23 04:41 PM
Pfeil Keith WSVP, Chief Financial OfficerAug 02Option Exercise53.2783344,374833Aug 03 06:14 PM
Pfeil Keith WSVP, Chief Financial OfficerAug 02Sale83.2483369,3390Aug 03 06:14 PM
Pfeil Keith WSVP, Chief Financial OfficerJul 19Option Exercise49.6583441,408834Jul 20 04:20 PM
Pfeil Keith WSVP, Chief Financial OfficerJul 19Sale78.2583465,2600Jul 20 04:20 PM
Scavilla Daniel TEVP, Chief Commercial OfficerJul 02Option Exercise25.89100,0002,589,500100,000Jul 07 04:46 PM
Scavilla Daniel TEVP, Chief Commercial OfficerJul 02Sale78.41100,0007,841,2240Jul 07 04:46 PM
Pfeil Keith WSVP, Chief Financial OfficerJul 01Option Exercise53.2783344,374833Jul 06 05:14 PM
Pfeil Keith WSVP, Chief Financial OfficerJul 01Sale77.4383364,4990Jul 06 05:14 PM
Pfeil Keith WSVP, Chief Financial OfficerJun 25Option Exercise51.5227,4791,415,61714,167Jun 28 04:52 PM
Pfeil Keith WSVP, Chief Financial OfficerJun 25Sale75.0427,4792,062,0240Jun 28 04:52 PM
TOBIN JAMES RDirectorMay 10Option Exercise43.7725,0001,094,25025,000May 12 04:38 PM
TOBIN JAMES RDirectorMay 10Sale71.9625,0001,799,0000May 12 04:38 PM
Pfeil Keith WSVP, Chief Financial OfficerMay 05Option Exercise49.655,021249,2935,021May 07 04:17 PM
Pfeil Keith WSVP, Chief Financial OfficerMay 05Sale75.005,021376,5750May 07 04:17 PM
Demski David MPresident, CEOApr 26Option Exercise27.66144,2633,990,213144,263Apr 27 04:18 PM
Demski David MPresident, CEOApr 26Sale71.50144,26310,314,8040Apr 27 04:18 PM
Demski David MPresident, CEOApr 23Option Exercise45.30121,2595,492,895121,259Apr 27 04:18 PM
Demski David MPresident, CEOApr 23Sale71.59121,2598,680,9320Apr 27 04:18 PM
Lemaitre DanDirectorMar 09Option Exercise11.2815,384173,53215,384Mar 11 04:39 PM
Lemaitre DanDirectorMar 09Sale62.4715,384961,0380Mar 11 04:39 PM
RHOADS ANN DDirectorMar 01Option Exercise10.6615,384163,99315,384Mar 03 04:32 PM
Huller KellySVP, GC, Corporate SecretaryDec 28Option Exercise11.282,00022,5602,000Dec 29 05:49 PM
Huller KellySVP, GC, Corporate SecretaryDec 28Sale66.152,000132,3000Dec 29 05:49 PM
Demski David MPresident, CEODec 17Option Exercise24.1015,864382,322164,719Dec 18 04:39 PM
Demski David MPresident, CEODec 17Sale64.20164,71910,574,9600Dec 18 04:39 PM
Demski David MPresident, CEODec 16Option Exercise27.9752,3561,464,516201,211Dec 18 04:39 PM
Demski David MPresident, CEODec 16Sale64.2052,3563,361,255148,855Dec 18 04:39 PM
Davidar David DDirectorNov 24Sale60.0010,000600,000205,967Nov 27 04:26 PM
Davidar David DDirectorNov 24Sale60.0032,0001,920,000634,775Nov 27 04:26 PM